The goal of this open label randomized trial is to understand the role of oral ursodeoxycholic acid(UDCA) supplementation in the liver regeneration (in terms of liver function and anatomical growth) following right lobe donor hepatectomy. The main question it aims to answer are: * Does Ursodeoxycholic acid supplementation on patients undergoing donor hepatectomy improve anatomical liver regeneration after partial hepatectomy as compared to control group. * Does ursodeoxycholic acid improve liver regeneration in terms of liver function tests and biomarkers of liver regeneration(HGF, IL6, TNF Alpha, AFP, TGF Beta) as compared to control group.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Regenerated liver volume on Post-operative Day 14 between two groups.
Timeframe: 14 days after operation
Regenerated liver volume on Post-operative Day 7 between two groups.
Timeframe: 7 days after operation
Percentage of Total Liver Volume Restored on Post-operative Day 7 between two groups.
Timeframe: 7 days after operation
Percentage of Liver Volume restored on Post-operative Day 14 between two groups.
Timeframe: 14 days after the operation
Absolute Liver Volume growth on Day 7
Timeframe: 7 days after the operation
Absolute Liver volume growth on day 14
Timeframe: 14 days after the operation
Regeneration Velocity on Post operative day 14, between both groups
Timeframe: 14 days after the operation